Concord Biotech Limited, an India-based R&D-driven biopharma company specializing in fermentation-based APIs for immunosuppressants and oncology, reported a decline in financial performance
(CONCORDBIO)
Concord Biotech Q1 FY26 Earnings Results
Concord Biotech Limited, incorporated in 1984, is an India-based R&D-driven biopharma company specializing in the manufacture of fermentation-based active pharmaceutical ingredients (APIs)
Concord Biotech Ltd Q4FY25; 47% rise in Profits
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology. Financial
Concord Biotech Ltd Q3FY25; 33% rise in Profits
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology. Financial
Concord Biotech Ltd Q2FY25; 19% rise in Profits
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology. Financial